Semi-comprehensive analysis of gene amplification in gastric cancers using multiplex ligation-dependent probe amplification and fluorescence in situ hybridization
Authors:
Open Access
- 1 June 2015
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 28 (6) , 861-871
Abstract
No abstract availableKeywords
Funding Information
- Smoking Research Foundation
- Ministry of Education, Culture, Sports, Science and Technology (25860266, C26460438, C25460452, C2546015, 26860235)
This publication has 33 references indexed in Scilit:
- Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registryGastric Cancer, 2012
- A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targetsGut, 2012
- FGFR2 gene amplification and clinicopathological features in gastric cancerBritish Journal of Cancer, 2012
- MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to CrizotinibJournal of Clinical Oncology, 2011
- C-MYC Alterations and Association With Patient Outcome in Early-Stage HER2-Positive Breast Cancer From the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab TrialJournal of Clinical Oncology, 2011
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other CancersThe American Journal of Pathology, 2010
- Non-incidental coamplification of Myc and ERBB2, and Myc and EGFR, in gastric adenocarcinomasLaboratory Investigation, 2007
- Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin‐3AInternational Journal of Cancer, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007